Security key
25056L103
Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN)
CUSIP: 25056L103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 61,880,773
- Total 13F shares
- 34,530,294
- Share change
- +119,913
- Total reported value
- $116,365,282
- Put/Call ratio
- 0%
- Price per share
- $3.37
- Number of holders
- 91
- Value change
- +$265,374
- Number of buys
- 40
- Number of sells
- 43
Report period
Q2 2025
Institutions
91
Top holders
10
DSGN full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Design Therapeutics, Inc. SEC filings
Design Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25056L103
Recent filing periods:
Top shareholders of DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Light Irrevocable Trust #1 dated April 22, 2019 |
13D/G
|
— |
6.9%
|
3,834,355
|
$16,257,665 | $0 | 31 Dec 2024 | |
| Star Irrevocable Trust #1 dated April 22, 2019 |
13D/G
|
— |
6.9%
|
3,834,355
|
$16,257,665 | $0 | 31 Dec 2024 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
11%
|
6,526,476
|
$25,192,197 | — | 31 Mar 2025 | |
| Logos Global Management LP |
13F
|
Company |
6.8%
|
4,217,627
|
$16,280,040 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4%
|
2,479,963
|
$9,572,657 | — | 31 Mar 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.2%
|
1,953,547
|
$7,540,691 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.9%
|
1,817,858
|
$7,016,932 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.8%
|
1,743,725
|
$6,730,779 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.7%
|
1,680,975
|
$6,488,564 | — | 31 Mar 2025 | |
| Almitas Capital LLC |
13F
|
Company |
2.3%
|
1,452,896
|
$5,608,179 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
1,427,467
|
$5,510,023 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.6%
|
963,460
|
$3,718,956 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
1.5%
|
948,050
|
$3,659,473 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
913,399
|
$3,525,720 | — | 31 Mar 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.5%
|
904,017
|
$3,489,506 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
775,497
|
$2,994,107 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
714,074
|
$2,756,326 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
1%
|
645,694
|
$2,492,379 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1%
|
630,953
|
$2,434,000 | — | 31 Mar 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.91%
|
562,943
|
$2,172,960 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.64%
|
395,251
|
$1,525,669 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
373,653
|
$1,442,300 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.47%
|
288,602
|
$1,114,841 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
266,016
|
$1,026,822 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.43%
|
265,000
|
$1,022,900 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.42%
|
258,375
|
$997,328 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.4%
|
247,878
|
$956,808 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.24%
|
147,228
|
$568,300 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.24%
|
146,700
|
$566,262 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.23%
|
141,519
|
$546,264 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.21%
|
128,747
|
$496,963 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
113,800
|
$439,268 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
95,348
|
$368,043 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
87,988
|
$339,634 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.14%
|
84,006
|
$324,264 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.12%
|
72,149
|
$278,000 | — | 31 Mar 2025 | |
| Lynx1 Capital Management LP |
13F
|
Company |
0.11%
|
65,954
|
$254,582 | — | 31 Mar 2025 | |
| Palumbo Wealth Management LLC |
13F
|
Company |
0.09%
|
58,278
|
$224,954 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.09%
|
56,405
|
$217,723 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.09%
|
52,872
|
$204,086 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
46,369
|
$178,975 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.07%
|
44,415
|
$171,442 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
43,223
|
$166,841 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.07%
|
42,090
|
$162,467 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.06%
|
36,917
|
$142,500 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
32,819
|
$126,681 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.05%
|
31,740
|
$122,516 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
28,129
|
$108,578 | — | 31 Mar 2025 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.04%
|
26,965
|
$104,085 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
22,879
|
$88,312 | — | 31 Mar 2025 |
Institutional Holders of Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN) as of Q2 2025
As of 30 Jun 2025,
Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,530,294 shares.
The largest 10 holders included
SR One Capital Management, LP, Logos Global Management LP, BlackRock, Inc., Frazier Life Sciences Management, L.P., Point72 Asset Management, L.P., TANG CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, Almitas Capital LLC, VANGUARD GROUP INC, and Driehaus Capital Management LLC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
95
Q2 2025 holders
91
Holder diff
-4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.